Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) commonly used to treat moderate to severe pain. It is available in both oral and injectable forms, and is generally considered safe when used as prescribed. However, like all medications, ketorolac can have some serious side effects. As such, it is important for doctors to be aware of these potential risks so that they can properly counsel their patients. In this article, we will take a comprehensive look at the hidden dangers of ketorolac and explore the potential side effects associated with its use.
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is used to treat pain. It is available in both oral and injectable forms, and is generally considered safe when used as prescribed. It works by blocking the production of certain chemicals in the body that cause pain and inflammation. Ketorolac is typically used to treat moderate to severe pain, such as that associated with arthritis, dental procedures, and traumatic injuries. It is also sometimes used to treat fever and inflammation.
Ketorolac is generally considered safe when used as prescribed. However, like all medications, it does carry the potential for side effects. Some of the most common side effects associated with ketorolac include nausea, vomiting, stomach pain, diarrhea, constipation, dizziness, headache, and drowsiness. In some cases, more serious side effects may occur, such as an increased risk of bleeding, kidney damage, and liver damage. It is important for doctors to be aware of these potential risks so that they can properly counsel their patients.
Certain individuals may be at an increased risk of experiencing side effects from ketorolac. These include people with a history of gastrointestinal problems, kidney or liver disease, and those taking other medications that may interact with ketorolac. It is important for doctors to ask their patients about their medical history and any other medications they may be taking before prescribing ketorolac.
Ketorolac should be taken exactly as prescribed by the doctor. The dosage and length of treatment will depend on the individual and the condition being treated. In general, ketorolac should not be taken for more than five days. Longer courses of treatment may increase the risk of side effects, so doctors should be sure to monitor their patients closely.
Ketorolac should not be taken by pregnant women, as it may cause harm to the fetus. Additionally, it should not be taken by people with a history of gastrointestinal bleeding or ulcers, as it can increase the risk of bleeding. It should also be avoided by those taking other medications that may interact with ketorolac, such as aspirin, warfarin, or other NSAIDs. Patients should be sure to inform their doctor of any other medications they are taking before starting ketorolac.
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) commonly used to treat moderate to severe pain. While it is generally considered safe when used as prescribed, it can have some serious side effects. As such, it is important for doctors to be aware of these potential risks so that they can properly counsel their patients. Patients should also be sure to inform their doctor of any other medications they are taking before starting ketorolac.
1.
Sub-Q Ketamine is Safe and Very Effective for Severe Depression.
2.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
3.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
4.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
5.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
3.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
4.
Polycythemia Vera: A Historical Perspective and Contemporary Management
5.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation